Hostname: page-component-cd9895bd7-dzt6s Total loading time: 0 Render date: 2024-12-22T17:16:09.015Z Has data issue: false hasContentIssue false
  • English
  • Français

Urinary Cyclic AMP in ‘Endogenous' and ‘Neurotic’ Depression

Published online by Cambridge University Press:  29 January 2018

K. Sinanan ,
A. M. B. Keatinge ,
P. G. S. Beckett  and
W. Clayton Love
K. Sinanan
Affiliation:
St. Patrick's Hospital; Trinity College, Dublin; Cluain Mhuire Family Centre, Newtownpark Avenue, Blackrock, Co. Dublin
A. M. B. Keatinge
Affiliation:
Department of Clinical Biochemistry, Trinity College, Dublin
P. G. S. Beckett
Affiliation:
Trinity College, Dublin
W. Clayton Love
Affiliation:
Federated Dublin Voluntary Hospitals; Trinity College, Dublin
Get access Rights & Permissions [Opens in a new window]

Extract

Since the discovery of adenosine 3'5'-cyclic monophosphate (cyclic AMP) by Sutherland and Rall (1958), the concept has evolved that this nucleotide acts as the second messenger substance for many neurotransmitter and hormone-induced responses (Sutherland, Robison and Butcher, 1968). Cyclic AMP occurs in high concentration in the brain. Cyclic AMP is functionally closely related, and possibly fundamental, to the action of catecholamines and serotonin, both of which have been implicated in the amine hypothesis of depression (Granville-Grossman, 1971). Cyclic AMP is formed from ATP by the action of an enzyme adenyl cyclase, and it is degraded by the enzyme cyclic-AMP-phosphodiesterase (Lancet, Editorial, 1970) both of which occur in brain.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 126 , Issue 1 , January 1975 , pp. 49 - 55
Copyright
Copyright © Royal College of Psychiatrists, 1975 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Abdulla, Y. H. & Hamadah, K. (1970) 3$5$ Cyclic adenosine monophosphate in depression and mania. Lancet, i, 378–81.Google Scholar
Brown, B. L., Salway, J. G., Albano, J. D. M., Hullin, R. P., and Ekins, R. P. Urinary excretion of cyclic AMP and manic-depressive psychoses. Brit. J. Psychiat. 120, 405–8.Google Scholar
Dousa, T. & Hechter, O. (1970) Lithium and brain adenyl cyclase. Lancet, i, 834–5.Google ScholarPubMed
Eccleston, D., Loose, R., Pullar, I. A. & Sugden, R. F. (1970) Exercise and urinary excretion of cyclic AMP. Lancet, ii, 612–13.Google Scholar
Gilman, A. (1970) A protein binding assay for adenosine 3$5$ cyclic monophosphate. Proceedings National Academy of Science, U.S.A., 67, 305–12.Google Scholar
Granville-Grossman, K. (1971) Recent Advances in Clinical Psychiatry, pp. 27–43. London: J. & A. Churchill.Google Scholar
Hamadah, K., Holmes, H., Barker, G. B., Hartman, G. C. & Parke, D. V. W. (1972) Effect of electric convulsion therapy on urinary excretion of 3$5$ cyclic adenosine monophosphate. British Medical Journal, iii, 439–41.Google Scholar
Hamilton, M. (1960) A rating scale of depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56–62.Google Scholar
Lancet, Editorial (1970) Cyclic AMP; the second messenger. Lancet, ii, 1119–21.Google Scholar
Lubin, B. (1965) An adjective check list of measurement of depression. Archives of General Psychiatry, 12, 57–62.Google Scholar
Miyamoto, E., Kuo, J. F. & Greengard, P. (1969) Cyclic nucleotide-dependent protein kinase. III. Purification and properties of adenosine 3$5$-monophosphate-dependent protein kinase from bovine brain. Journal of Biological Chemistry, 244, 6395–402.Google Scholar
Murad, F. & Pak, C. Y. C. (1972) Urinary excretion of adenosine 3$5$ monophosphate and guanosine 3$5$-monophosphate. New England Journal of Medicine, 286, 1382–7.Google Scholar
Paul, M. I., Cramer, H. & Bunny, W. E. (1971) Urinary adenosine 3$5$-monophosphate in the switch process from depression to mania. Science, 171, 300–303.Google Scholar
Paul, M. I. & Goodwin, F. K. (1971) Urinary cyclic AMP excretion in depression and mania, effects of levodopa and lithium carbonate. Archives of General Psychiatry, 24, 327–33.Google Scholar
Paul, M. I., Dttzion, B. R., Pauk, G. L. & Janowsxy, D. S. (1970) Urinary adenosine 3$5$-monophosphate excretion in affective disorders. American Journal of Psychiatry, 126(10), 1493–7.Google Scholar
Ramsden, E. N. (1970) Cyclic AMP in depression and mania. Lancet, ii, 108.Google Scholar
Sutherland, E. W. & Rall, T. W. (1958) Fractionation and characterization of a cyclic adenine ribonucleotide formed by tissue particles. Journal of Biological Chemistry, 232, 1077.Google Scholar
Sutherland, E. W., Robison, A. G. & Butcher, R. W. (1968) Some aspects of the biological role of adenosine 3$5-monophosphate (cyclic AMP). Circulation, 37, 279–306.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.